Home/Synendos Therapeutics/Dr. George Garibaldi, MD

DG

Dr. George Garibaldi, MD

Chief Medical Officer

Synendos Therapeutics

Therapeutic Areas

Psychiatry Neuroscience

Synendos Therapeutics Pipeline

Drug	Indication	Phase
SYT-510	General Anxiety Disorder (GAD), Post-Traumatic Stress Disorder (PTSD)	Phase 1

Leadership Team at Synendos Therapeutics

Dr. Andrea Chicca

Co-Founder & Chief Executive Officer

Dr. Simon Russell

Co-Founder & Chief Commercial Officer

Prof. Dr. Jürg Gertsch

View full Synendos Therapeutics profile